Page last updated: 2024-10-20

uric acid and Leukemia L 1210

uric acid has been researched along with Leukemia L 1210 in 2 studies

Uric Acid: An oxidation product, via XANTHINE OXIDASE, of oxypurines such as XANTHINE and HYPOXANTHINE. It is the final oxidation product of purine catabolism in humans and primates, whereas in most other mammals URATE OXIDASE further oxidizes it to ALLANTOIN.
uric acid : An oxopurine that is the final oxidation product of purine metabolism.
6-hydroxy-1H-purine-2,8(7H,9H)-dione : A tautomer of uric acid having oxo groups at C-2 and C-8 and a hydroxy group at C-6.
7,9-dihydro-1H-purine-2,6,8(3H)-trione : An oxopurine in which the purine ring is substituted by oxo groups at positions 2, 6, and 8.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Henderson, GB2
Tsuji, JM1

Other Studies

2 other studies available for uric acid and Leukemia L 1210

ArticleYear
Identification of cholate as a shared substrate for the unidirectional efflux systems for methotrexate in L1210 mouse cells.
    Biochimica et biophysica acta, 1990, Jan-23, Volume: 1051, Issue:1

    Topics: Animals; Biological Transport; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Cholic Acids; Cytochalasin

1990
Mediation of cellular anion detoxification in leukemic cells by unidirectional efflux pumps.
    Advances in enzyme regulation, 1989, Volume: 29

    Topics: Animals; Anions; Biological Transport; Cholic Acids; Cyclic AMP; Drug Resistance; Folic Acid; Leukem

1989